MMS Holdings, a Canton-based data-focused contract research organization (CRO), has expanded its leadership team with the appointment of Chris Schoonmaker as chief operating officer and Ashu Tandon as chief commercial officer.
Both Schoonmaker and Tandon have decades of experience in the pharmaceutical and health care industries and have held leadership positions at other CROs.
“We are excited to welcome Chris and Ashu to the #OneMMS team,” says Uma Sharma, CEO of MMS. “I look forward to their leadership and strength for our continued growth as we scale our teams and clients globally to be the best in business.”
The expansion of the MMS executive leadership team, including the newly created position of chief commercial officer, will allow the company to continue growing its teams and services across its global operations.
“I’m excited to join and help expand MMS’ reach as we continue to bring value to sponsors by helping them bring new therapies to market,” says Tandon. “We have strong expertise across our many services, and I look forward to connecting sponsors with the MMS services that are the right fit for their needs.”
MMS has maintained one of the highest retention rates in the pharma industry. These aspects of MMS enhance its mission of delivering high-quality service and technology solutions to assist clients in developing life-changing therapies.
“I’m grateful to work at a company with such a strong company culture that cares about its colleagues,” says Schoonmaker. “Being a part of growing the company and developing the business strategies and operational excellence needed to continue our success is exciting and rewarding to me after many years in this space.”
